Advicenne Pharma

Pre-Approval PRO BETA

🟡

No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 2/25/2025

Total Trials

Phase 3

Phase 2

Recruiting

Score

Pipeline by Phase

Phase 3

Phase 2

Phase 1

Cystinuria EFFECT OF ADV7103 ON GASTRIC PH Distal Renal Tublular Acidosis Acidosis, Renal Tubular Distal Renal Tubular Acidosis

NCT03831152 Phase 3 WITHDRAWN

Extension Study in Primary Distal Renal Tubular Acidosis

Started: 12/20/2023

NCT03644706 Phase 3 TERMINATED

Study Evaluating Subjects With Distal Renal Tubular Acidosis

Started: 9/20/2021

NCT04147871 Phase 2 WITHDRAWN

Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children

Started: 3/1/2024

NCT04137978 Phase 2 WITHDRAWN

Study Evaluating Patients With Cystinuria

Started: 5/1/2024

NCT07446881 Phase 1 COMPLETED

A Phase 1 Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants.

Started: 2/25/2025

ADV7103 Placebo Standard of Care

Activity Status: Slowing

Last Trial Started: 2/25/2025

Last Trial Ended: 3/15/2025

Trials (12 months): 0

Completed Trials: 1

Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.